================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): April 22, 2005


                       PROTEIN POLYMER TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)



            Delaware                       0-19724               33-0311631
-----------------------------------  -------------------  ----------------------
 (State or other jurisdiction of         (Commission           (IRS Employer
  incorporation or organization)         File Number)        Identification No.)



    10655 Sorrento Valley Road, San Diego, California               92121
---------------------------------------------------------  ---------------------
         (Address of principal executive offices)                 (Zip Code)



    Registrant's telephone number, including area code:  (858) 558-6064
                                                         -----------------------

                                 Not Applicable
 -------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)


================================================================================





Item 1.01.  Entry into a Material Definitive Agreement.

                  On April 22, 2005, at a meeting of the Board of Directors, the
Board of Directors resolved that Mr. William N. Plamondon III, the Registrant's
recently appointed Chief Executive Officer, would receive a warrant entitling
him to purchase an aggregate of 2,000,000 shares of the Registrant's common
stock at an exercise price equal to the market price of the Registrant's common
stock at the close of the market on the date of the grant, $0.67 per share. The
warrants are immediately exercisable and expire three years after the date of
the grant.

Item 5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.


         At the same meeting as described in Item 1.01 to this Current Report on
Form 8-K, the Board of Directors of the Registrant elected James B. McCarthy to
the Registrant's Board. Mr. McCarthy was appointed at the same meeting to serve
as a member of the Stock Option and Compensation Committee of Board of
Directors.

         On April 25, 2005, the Registrant issued a press release announcing the
election. A copy of the press release is filed as Exhibit 99.1 to this Current
Report on Form 8-K.

Item 9.01.  Financial Statements and Exhibits.

         (c) Exhibits.

                  99.1       Press Release of Protein Polymer Technologies, Inc.
                             dated April 25, 2005





                                    SIGNATURE

                  Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                     PROTEIN POLYMER TECHNOLOGIES, INC.,
                                     a Delaware corporation


Date: April 28, 2005                 By: /s/ J. Thomas Parmeter
                                         ---------------------------------------
                                          J. Thomas Parmeter
                                          Chairman of the Board





                                  EXHIBIT INDEX

Exhibit No.                Description
-----------                -----------

99.1                         Press Release of Protein Polymer Technologies, Inc.
                             dated April 25, 2005